This post uses hypothetical scenarios for illustrative purposes only. It does not describe any actual client, transaction, or representation, and is not legal advice.
Picture a typical Florida independent pharmacy sale. An owner who has run a community pharmacy for two decades — building the kind of patient relationships the chains keep trying to buy — agrees to sell to a younger pharmacist who wants to own rather than work for a corporate banner. The price is fair, the financing is lined up, and both sides assume the hard part is behind them. Then the question comes up at the closing table that nobody costed: on the day after closing, whose name is on the pharmacy permit, and who is allowed to dispense the controlled substances sitting on the shelf?
The answer is the part that catches people. A Florida pharmacy permit is not a piece of property that conveys with the bill of sale. It is not transferable at all. When the pharmacy changes hands, the buyer does not inherit the seller’s permit — the buyer applies for a new one, and the Board of Pharmacy issues a new permit number. The same is true at the federal level for the controlled-substance registration. The deal can be papered as a clean asset sale, but the two things that actually let a pharmacy operate — the state permit and the DEA registration — have to be re-created in the buyer’s name, on the regulators’ timetable, not the parties’.
The permit does not transfer — a fresh one issues
The governing provision is section 465.022 of the Florida Statutes, which sets up the pharmacy permit regime and directs the Board of Pharmacy to adopt change-of-ownership rules, including how prescription files and medicinal drugs are handled when a pharmacy changes hands or closes. The operative reality, carried through the Board’s rules, is straightforward and unforgiving: the permit is not transferable, and on the sale of an existing pharmacy a new application has to be filed. Because every change of ownership results in a new permit number, the buyer is, for regulatory purposes, opening a pharmacy — not stepping into the seller’s shoes.
That single fact ripples through the structure. The buyer’s right to operate is contingent on the new permit issuing, so the purchase agreement has to treat the permit like the closing condition it is. The prescription files — the patient records that are a large part of what the buyer is paying for — have to be transferred under the Board’s procedures, not just handed over. And the seller cannot simply stop being responsible the moment the keys change hands, because until the buyer’s permit issues, the lawful authority to dispense still runs through the seller’s permit.
The DEA side is its own transaction
Federal controlled-substance authority is separate, and it is the part most likely to trip an unprepared buyer. The DEA registration, like the state permit, does not transfer; the buyer obtains a new registration using the same procedures as a new establishment, because the change of ownership produces a new permit number to which the federal registration must attach. The controlled-substance inventory cannot just be left on the shelf and inherited. If the existing pharmacy carries controlled substances, the new permit has to record an opening inventory for DEA purposes, and both the old and the new permit holders have to keep records of the transfer of legend drugs and controlled substances — generally for two years — so the chain of custody is documented end to end.
Practically, that means the closing is not one event but a choreographed handoff. The controlled-substance inventory has to be counted and documented as it moves from the seller’s authority to the buyer’s, the transfer records have to be created contemporaneously, and the buyer cannot dispense controlled substances until its own registration is in place. A purchase agreement that ignores this leaves a gap — a day, a week, longer — in which the pharmacy either cannot fill controlled-substance prescriptions or someone is operating outside their authority. Neither is acceptable, and the fix is to sequence the regulatory steps into the closing mechanics rather than treating them as post-closing cleanup.
Asset sale, but watch the successor-liability seams
Most pharmacy deals are structured as asset purchases, partly because the buyer wants a fresh start on the permit and registration anyway and partly to avoid inheriting the seller’s liabilities. But “asset sale” is not a magic phrase that severs everything. Florida’s successor-liability doctrines can follow assets into the buyer’s hands when the buyer is, in substance, a mere continuation of the seller — same location, same staff, same patients, same signage. A pharmacy is the textbook fact pattern for that argument, so the buyer should be deliberate about the diligence and the indemnity package rather than assuming the asset structure does the work by itself.
Tax is the other seam. Florida imposes its own diligence discipline on asset buyers, and a buyer that does not confirm the seller’s tax position can inherit exposure. A tax clearance certificate is the mechanism that protects an asset buyer from the seller’s unpaid sales tax, and in a retail pharmacy with front-of-store sales it is worth the step. The point is the same across all of these: the asset structure helps, but only if the buyer uses the tools that come with it.
The diligence that decides the number
Beyond the permits, two diligence items move a pharmacy’s price. The first is the third-party-payer and PBM contracts, plus the reimbursement and DIR-fee exposure that come with them. The economics of a modern pharmacy live in those contracts, and many do not assign without consent — meaning the buyer’s projected revenue depends on agreements the buyer may have to re-paper or renegotiate. The second is inventory valuation and the wholesaler relationships, including any returns, chargebacks, or 340B arrangements. A pharmacy’s balance sheet is heavy on inventory, and the way that inventory is valued and transferred — controlled and non-controlled alike — is real money at the closing adjustment.
There is a third item that buyers underweight: the location itself. Both the state permit and the DEA registration attach to a specific address, so a pharmacy permit is, in a real sense, a permission to operate at one place. That ties the deal to the real estate. Most pharmacies lease, and the lease typically requires landlord consent to assignment or change of control — and because the buyer is technically opening a new permitted establishment at the same address, the timing of the lease assignment has to line up with the timing of the permit issuance. If the lease lapses or the assignment stalls, the buyer’s brand-new permit has no place to live. Patient-record continuity adds a further wrinkle: the prescription files have to be transferred under the Board’s procedures, and patients generally expect their pharmacy relationship to continue seamlessly, so the notification and file-migration mechanics belong in the closing checklist rather than in an afterthought.
The takeaway
Selling a Florida pharmacy is not the transfer of a license; it is the retirement of one and the creation of another. Section 465.022 makes the permit non-transferable, the DEA registration is its own separate re-application, and the controlled-substance inventory has to move by the book with documented opening inventory and transfer records on both sides. Build the close around those steps instead of discovering them at the table. Use the asset structure deliberately — successor liability and unpaid tax can still follow the assets if you do not. And pin down the payer contracts and the inventory valuation before diligence, because that is where the agreed number quietly gets re-decided.
Our Fernandina Beach office works with independent pharmacy owners and buyers on acquisitions and exits throughout Florida, from Jacksonville to Tampa, Orlando, and South Florida.
If you are buying or selling a Florida pharmacy and want the permit, DEA, and controlled-substance steps sequenced before you sign, feel free to reach out to my firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.
